MedTech Dive January 25, 2024
The decision comes just weeks after Medtronic received approval for its latest rechargeable device.
Dive Brief:
- Abbott received approval from the Food and Drug Administration for a rechargeable deep brain stimulation (DBS) system.
- Abbott claimed in the Thursday announcement its device, called Liberta RC, is the world’s smallest and has the longest charge of any DBS technology on the market. The company says the device only needs to be recharged 10 times per year under standard settings for most users.
- Earlier this month, Medtronic also received approval for a new DBS system called Percept RC, which has sensing technology to track patients’ response to treatment.
Dive Insight:
DBS is used to treat movement conditions, such as Parkinson’s...
Today's Sponsors
Today's Sponsor